🇮🇳IN
Sign In
VE

VENUSREM

NSE

Venus Remedies Ltd

₹1,404.30

-37.20(-2.58%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

VENUSREM financial summary

For Mar 2026, Venus Remedies Ltd reported revenue of ₹765 crore, which grew 20.3% from the previous year. Net profit was ₹99 crore, which grew 86.8% year on year, on an operating margin of 19%. Earnings per share came in at ₹74.29. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.

Revenue₹765 crore
Net profit₹99 crore
Operating margin19%
EPS₹74.29

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer